Smedemark, Siri Aas
Laursen, Christian B.
Jarbøl, Dorte Ejg
Rosenvinge, Flemming S.
Andersen-Ranberg, Karen
Funding for this research was provided by:
University of Southern Denmark
Article History
Received: 23 February 2023
Accepted: 3 February 2024
First Online: 16 February 2024
Declarations
:
: The study protocol was submitted to the Regional Committees on Health Research Ethics for Southern Denmark, who approved the study (S-20220050). The ethical principles for medical research as stated by the Declaration of Helsinki, will be applied throughout the study [CitationRef removed]. All methods will also follow guidelines and regulations given by the Regional Committees on Health Research Ethics for Southern Denmark. All participants will provide written informed consent. ACNs will seek written consent. The consent forms and process have been ethically reviewed by the Regional Committees on Health Research Ethics for Southern Denmark.
: Not applicable.
: SAS declare no competing interest.CBL has in the past 36 months received speaker’s honoraria for lectures at educational events / symposia / courses organised by AstraZeneca, and royalties as author of book chapters or as editor of books / web publications by Munksgaard.DEJ declare no competing interest.FSR declare no competing interest.KAR declare no competing interest.